Background In this study, we tested the hypothesis that a combined adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat …

Backgrounds Despite the potential therapeutic benefits, cell therapy in renal ischemia-
reperfusion (I/R) injury is currently limited by low rates of cell engraftment after systemic …

Mesenchymal stem cells are currently considered as a promising tool for therapeutic
application in acute kidney injury (AKI) management. AKI is characterized by acute tubular …

The present study aimed to investigate the invitro preconditioning of adipose-derived
mesenchymal stem cells (ADMSCs) with CD44-targeted hyalournic acid (HA) on ischemic …

Biological scaffolds based stem cell delivery methods have emerged as a promising
approach for tissue repair and regeneration. Here we developed a hydrogel biological …

Acute kidney injury (AKI) is a rapid loss of renal function. It has high mortality rates. Still,
renal replacement therapy is considered the best solution for recovering AKI. This opens a …

Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only
supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells …

Renal resident mesenchymal stem cells (MSCs) are important regulators of kidney
homeostasis, repair or regeneration. However, natural distribution and the starting …

Introduction This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic
adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of …

Acute kidney injury (AKI) has emerged as a major public health problem affecting millions of
people worldwide without specific and satisfactory therapies due to the lack of an effective …